Dopamine News and Research

Latest Dopamine News and Research

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with Parkinson's-related psychosis.

14 Oct 2019

Scientists identify strong genetic markers for PTSD

Post-traumatic stress disorder (PTSD) is the most commonly occurring and seriously debilitating disorder that happens when a person gets exposed to traumatic events, including sexual assault, combat, and natural disaster.

9 Oct 2019

GUMC now offers three clinical trials to study treatments for LBD

Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson's and Alzheimer's disease.

8 Oct 2019

New NIH grant to support innovative skin testing approach for diagnosing Parkinson's disease

Wenquan Zou, MD, PhD, an expert in degenerative neurological diseases, along with his collaborators Shu G. Chen, PhD also from the Case Western Reserve University School of Medicine, Jiyan Ma, MD, PhD, from Van Andel Institute in Grand Rapids, Michigan, and Thomas Beach, MD, PhD, from Banner Sun Health Research Institute, Sun City, Arizona, have received a five-year, $3.6 million grant from the National Institutes of Health for diagnosing Parkinson's disease (PD) via an innovative skin testing approach.

4 Oct 2019

New study shows link between antidepressant use and gestational diabetes mellitus

A study has found a link between the use of antidepressants and the development of gestational diabetes mellitus (GDM) in pregnant women.

2 Oct 2019

Cannabis: CBD vs THC causes lower psychiatric side-effects

A study has revealed how cannabidiol works against tetrahydrocannabinol to prevent psychiatric side effects.

1 Oct 2019

Researchers identify genetic variants related to starting point of Parkinson's disease

Researchers from the Institute of Neurosciences of the University of Barcelona, Hospital Clínic and the August Pi i Sunyer Biomedical Research Institute have identified a group of genetic variants related to the starting point of Parkinson's disease.

27 Sep 2019

Researchers identify neural circuit that controls perseverance

Success is no accident: To reach your goal you need perseverance. But where does the motivation come from? An international team of researchers led by scientists from the Technical University of Munich (TUM) has now identified the neural circuit in the brain of fruit flies which makes them perform at their best when searching for food.

27 Sep 2019

Research reveals molecular link between chronic pain and depression

Researchers at Hokkaido University have identified the brain mechanism linking chronic pain and depression in rats. Their research, which was recently published in The Journal of Neuroscience, could lead to the development of new treatments for chronic pain and depression.

26 Sep 2019

Genetic engineering could open possibilities for patients with Parkinson’s disease

People with Parkinson’s disease experience loss of dopamine-producing brain cells, leading to tremors, rigidity, bradykinesia, and postural instability, the primary symptoms of the disease.

11 Sep 2019

Brain circuit regulates individual responses to temptation cues, rat study finds

Differences in a key brain circuit may suggest why some individuals are less able than others to resist tempting cues, according to a study in rats published today in eLife.

11 Sep 2019

New oral splint can reduce tics in children and adults with Tourette syndrome

Tourette syndrome is a neurological disorder characterized by vocal and motor tics, which can contribute to anxiety, depression, and low self-esteem.

10 Sep 2019

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Scientists at The University of Texas at Dallas have found evidence suggesting that resistance to the "hunger hormone" ghrelin in the brain is linked to the cognitive impairments and memory loss associated with Alzheimer's disease.

4 Sep 2019

Investigational drug reduces stuttering symptoms in open-label pilot study

A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.

28 Aug 2019

Neurological markers in the brain can help detect people at risk for psychotic disorders

Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.

27 Aug 2019

Research explains why many psychiatric drugs that work in the lab don’t work in people

Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.

22 Aug 2019

Johns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptoms

In a new study of seven people with Parkinson’s disease, Johns Hopkins Medicine researchers report evidence that deep brain stimulation using electrical impulses jumpstarts the nerve cells that produce the chemical messenger dopamine to reduce tremors and muscle rigidity that are the hallmark of Parkinson’s disease, and increases feelings of well-being.

From Johns Hopkins Medicine 21 Aug 2019

Dopamine News and Research

Latest Dopamine News and Research

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

Scientists identify strong genetic markers for PTSD

GUMC now offers three clinical trials to study treatments for LBD

New NIH grant to support innovative skin testing approach for diagnosing Parkinson's disease

New study shows link between antidepressant use and gestational diabetes mellitus

Cannabis: CBD vs THC causes lower psychiatric side-effects

Researchers identify genetic variants related to starting point of Parkinson's disease

Researchers identify neural circuit that controls perseverance

Research reveals molecular link between chronic pain and depression

Genetic engineering could open possibilities for patients with Parkinson’s disease

Brain circuit regulates individual responses to temptation cues, rat study finds

New oral splint can reduce tics in children and adults with Tourette syndrome

Resistance to 'hunger hormone' linked with cognitive impairments and memory loss

Investigational drug reduces stuttering symptoms in open-label pilot study

Neurological markers in the brain can help detect people at risk for psychotic disorders

Research explains why many psychiatric drugs that work in the lab don’t work in people

Johns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptoms

Genetic variant increases risk of addiction in the presence of childhood stress

MRI scans show how ADHD medication affects brain structure in children

New study explores the effects of cannabis on brain neurochemistry

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in